Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R.P. Scherer Technologies is a foundational drug delivery company best known for inventing the rotary die encapsulation process for softgel capsules. Founded in 1933 by Robert Pauli Scherer, the company revolutionized the pharmaceutical industry by enabling the mass production of uniform, hermetically sealed gelatin capsules. Following its acquisition by Cardinal Health in 1998, the company's operations and intellectual property became the backbone of Catalent Pharma Solutions. R.P. Scherer's legacy includes the development of the Zydis fast-dissolving tablet technology and a wide array of oral, inhalation, and topical delivery systems. The company currently operates as a key technology subsidiary within Catalent, providing specialized manufacturing and formulation expertise to global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R.P. Scherer Technologies.